Cargando…
Second Primary Neoplasms in Thyroid Cancer Patients
To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921095/ https://www.ncbi.nlm.nih.gov/pubmed/8613424 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x |
_version_ | 1783317937244864512 |
---|---|
author | Ishikawa, Kazuhiro Noguchi, Shiro Tanaka, Keitaro Fukuda, Atsushi Hirohata, Tomio |
author_facet | Ishikawa, Kazuhiro Noguchi, Shiro Tanaka, Keitaro Fukuda, Atsushi Hirohata, Tomio |
author_sort | Ishikawa, Kazuhiro |
collection | PubMed |
description | To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They were followed from the date of operation through the end of 1990 with an observation period from 45 to 5 years. The average observation period of the patients was 13.4 years and the follow‐up rate reached 98%. The standardized mortality ratio (SMR) was computed to assess possible risk increase by cancer site. In this computation, the time period less than 5 years after operation was omitted to reduce the influence of deaths related to the original thyroid cancer. A total of 103 deaths from malignant neoplasms other than thyroid cancer were observed during this time period (SMR=1.6, 95% confidence interval [CI]=1.3–2.0). Analyses of site‐specific cancer mortality revealed significantly elevated risks for the central nervous system (SMR=16.1, CI=5,2–37.6) and respiratory organs (SMR=2.6, CI=1.5–4.1). Based on a review of available medical records with histological findings, we concluded that the risk increases for these sites were most likely to be attributable to second primary neoplasms. Whether or not the patients had received radiotherapy was not significantly associated with elevated risk. Further investigations are needed to clarify the risk factors responsible for the above findings. |
format | Online Article Text |
id | pubmed-5921095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59210952018-05-11 Second Primary Neoplasms in Thyroid Cancer Patients Ishikawa, Kazuhiro Noguchi, Shiro Tanaka, Keitaro Fukuda, Atsushi Hirohata, Tomio Jpn J Cancer Res Article To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They were followed from the date of operation through the end of 1990 with an observation period from 45 to 5 years. The average observation period of the patients was 13.4 years and the follow‐up rate reached 98%. The standardized mortality ratio (SMR) was computed to assess possible risk increase by cancer site. In this computation, the time period less than 5 years after operation was omitted to reduce the influence of deaths related to the original thyroid cancer. A total of 103 deaths from malignant neoplasms other than thyroid cancer were observed during this time period (SMR=1.6, 95% confidence interval [CI]=1.3–2.0). Analyses of site‐specific cancer mortality revealed significantly elevated risks for the central nervous system (SMR=16.1, CI=5,2–37.6) and respiratory organs (SMR=2.6, CI=1.5–4.1). Based on a review of available medical records with histological findings, we concluded that the risk increases for these sites were most likely to be attributable to second primary neoplasms. Whether or not the patients had received radiotherapy was not significantly associated with elevated risk. Further investigations are needed to clarify the risk factors responsible for the above findings. Blackwell Publishing Ltd 1996-03 /pmc/articles/PMC5921095/ /pubmed/8613424 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x Text en |
spellingShingle | Article Ishikawa, Kazuhiro Noguchi, Shiro Tanaka, Keitaro Fukuda, Atsushi Hirohata, Tomio Second Primary Neoplasms in Thyroid Cancer Patients |
title | Second Primary Neoplasms in Thyroid Cancer Patients |
title_full | Second Primary Neoplasms in Thyroid Cancer Patients |
title_fullStr | Second Primary Neoplasms in Thyroid Cancer Patients |
title_full_unstemmed | Second Primary Neoplasms in Thyroid Cancer Patients |
title_short | Second Primary Neoplasms in Thyroid Cancer Patients |
title_sort | second primary neoplasms in thyroid cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921095/ https://www.ncbi.nlm.nih.gov/pubmed/8613424 http://dx.doi.org/10.1111/j.1349-7006.1996.tb00211.x |
work_keys_str_mv | AT ishikawakazuhiro secondprimaryneoplasmsinthyroidcancerpatients AT noguchishiro secondprimaryneoplasmsinthyroidcancerpatients AT tanakakeitaro secondprimaryneoplasmsinthyroidcancerpatients AT fukudaatsushi secondprimaryneoplasmsinthyroidcancerpatients AT hirohatatomio secondprimaryneoplasmsinthyroidcancerpatients |